Curtis Paul

Curtis M. Paul serves as a Contracting Officer responsible for managing the full lifecycle of federal acquisitions, from solicitation through contract award and administration. He plays a critical role in advancing his agency’s mission by ensuring compliance with federal procurement regulations while delivering high-value technical services. His portfolio is exclusively focused on research and development contracts under NAICS 541712, encompassing physical, engineering, and life sciences research—such as laboratory testing, data analytics, prototype development, and scientific instrumentation. His acquisitions are structured to support innovation, technical excellence, and mission-critical scientific advancement. While specific contractor names are not available, Curtis maintains a procurement environment that prioritizes collaboration with small businesses capable of delivering specialized R&D services. His contracting patterns reflect a disciplined, transparent approach to vendor engagement, fostering long-term partnerships with firms possessing deep technical expertise in scientific domains. He actively manages contract performance, risk mitigation, and compliance, ensuring deliverables meet stringent federal standards for quality and accountability. Curtis demonstrates an unwavering commitment to socioeconomic goals, with 100% of his acquisitions set aside exclusively for small businesses under FAR 19.5. This consistent application of small business set-asides underscores his dedication to expanding market access for entrepreneurial firms and promoting equitable participation in federal science and engineering contracts. His approach aligns with broader government objectives to strengthen the small business industrial base through targeted, non-competitive procurement mechanisms. His primary technical focus lies in NAICS 541712, where he procures advanced scientific services including experimental design, computational modeling, materials characterization, and applied research in engineering and life sciences. He works closely with firms that bring niche capabilities in laboratory automation, data-driven research methodologies, and interdisciplinary scientific innovation, ensuring the agency’s R&D objectives are met with precision and regulatory integrity.